Timothee Revil

Montreal, QC H3A0C7, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

The Genetic and Molecular Analyses of Rare Candidate Germline BRIP1/FANCJ Variants Implicated in Hereditary Breast and Ovarian Cancers.

The Genetic and Molecular Analyses of Rare Candidate Germline BRIP1/FANCJ Variants Implicated in Hereditary Breast and Ovarian Cancers.

Journal: International journal of molecular sciences
Published: October 03, 2025

Co-occurring rare germline DNA repair gene variants in BRCA1/BRCA2 implicated hereditary breast cancer families.

Co-occurring rare germline DNA repair gene variants in BRCA1/BRCA2 implicated hereditary breast cancer families.

Journal: NPJ breast cancer
Published: June 23, 2025

Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene.

Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene.

Journal: Genes
Published: December 01, 2022

Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases.

Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases.

Journal: Frontiers in oncology
Published: November 29, 2022

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population.

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population.

Journal: Cancers
Published: March 18, 2022

Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants.

Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants.

Journal: Genes
Published: March 08, 2022

A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.

A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.

Journal: Genome medicine
Published: September 02, 2020

Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.

Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.

Journal: Human mutation
Published: June 02, 2020

DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis.

DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis.

Journal: The Journal of clinical investigation
Published: May 10, 2019

Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.

Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.

Journal: Scientific reports
Published: January 03, 2019

Analysis of DICER1 in familial and sporadic cases of transposition of the great arteries.

Analysis of DICER1 in familial and sporadic cases of transposition of the great arteries.

Journal: Congenital heart disease
Published: August 08, 2017

A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer.

A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer.

Journal: Cell reports
Published: July 18, 2017
Showing 1-12 of 20

Last Updated: 09/26/2026